Tag Archives: Oligodendroglioma
The brain tumor community is dedicated to fighting one of the toughest battles imaginable. Thus we are all – from patients, to caregivers, to doctors, to scientists, to advocates – constantly looking forward to the next hurdle we have to jump on our mission toward a cure. Here at the National Brain Tumor Society, specifically, [...]
Dr. David Louis, Pathologist-in-Chief at Massachusetts General Hospital (MGH) and Benjamin Castleman Professor of Pathology at Harvard Medical School, is an internationally recognized expert in brain tumor pathology and molecular genetics.
The National Brain Tumor Society and OligoNation announced Dr. David Louis, MD, of Massachusetts General Hospital and Harvard Medical School, and Dr. Anders Persson, PhD, of The University of California, San Francisco as the first grant recipients of the Oligodendroglioma Research Fund.